Raes M, Kellum J A, Colman R, Wallaert S, Crivits M, Viaene F, Hemeryck M, Benoit D, Poelaert J, Hoste E
Department of Intensive Care Medicine, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium.
Department of Anesthesiology, Brussels University Hospital, Brussels, Belgium.
J Nephrol. 2024 Jun;37(5):1299-1308. doi: 10.1007/s40620-024-01912-z. Epub 2024 Mar 28.
To compare the short-term effects on acid base, electrolyte status and urine output of a single fluid bolus of saline to that of the balanced solution Plasmalyte in critically ill patients.
Prospective, randomized, controlled trial. Adult patients (≥ 18 years) admitted to the ICU receiving a fluid bolus were randomized to receive 1 L of saline (NaCl 0.9%, Baxter) or a balanced fluid [Plasmalyte (Baxter)]. Blood samples and urine output were collected just before (T0), just after (T1), 2 h after (T2) (only for urinary output) and three hours after termination of the fluid bolus (T4). The effect of fluid boluses on serum chloride, apparent strong ion difference, base excess, urinary output and blood pressure or vasopressor need were analyzed.
Patients who received a 1 L saline fluid bolus had a significant increase in serum chloride (1.60; 95% CI 1.10 to 2.10; P < 0.001) and short-term decrease in apparent strong ion difference (- 1.85; 95% CI - 2.71 to - 0.99; P < 0.001) and base excess (- 0.90; 95% CI - 1.31 to - 0.50; P < 0.001). We observed a 17% increase in patients developing hyperchloremia in the saline group (0.17; 95% CI 0.05 to 0.29; P = 0.005). No significant difference in urinary output, blood pressure or vasopressor need was observed in either group.
Even a single, small bolus of saline, administered to critically ill patients, causes a significant increase in chloride concentration and a decrease in apparent strong ion difference and base excess, and an increase in the number of patients developing hyperchloremia. No difference in effect on urinary output, blood pressure or vasopressor need was observed between the two groups.
2014-001005-41; date of registration: 28/10/2014.
EC project number 2014/038.
比较单次静脉推注生理盐水与平衡液Plasmalyte对重症患者酸碱、电解质状态及尿量的短期影响。
前瞻性、随机、对照试验。入住重症监护病房(ICU)且接受液体推注的成年患者(≥18岁)被随机分为两组,分别接受1升生理盐水(0.9%氯化钠,百特公司生产)或平衡液[Plasmalyte(百特公司生产)]。在推注液体前(T0)、推注后即刻(T1)、推注后2小时(T2,仅记录尿量)以及推注结束后3小时(T4)采集血样和尿量。分析液体推注对血清氯、表观强离子差、碱剩余、尿量、血压或血管升压药使用需求的影响。
接受1升生理盐水推注的患者血清氯显著升高(1.60;95%置信区间1.10至2.10;P<0.001),表观强离子差短期降低(-1.85;95%置信区间-2.71至-0.99;P<0.001),碱剩余降低(-0.90;95%置信区间-1.31至-0.50;P<0.001)。我们观察到生理盐水组发生高氯血症的患者增加了17%(0.17;95%置信区间0.05至0.29;P=0.005)。两组在尿量、血压或血管升压药使用需求方面均未观察到显著差异。
即使对重症患者单次小剂量推注生理盐水,也会导致氯浓度显著升高,表观强离子差和碱剩余降低,以及发生高氯血症的患者数量增加。两组在对尿量、血压或血管升压药使用需求的影响方面未观察到差异。
2014-001005-41;注册日期:2014年10月28日。
EC项目编号2014/038。